您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:海普瑞:截至二零二五年十二月三十一日止年度全年业绩公告及建议变更未动用所得款项净额用途 - 发现报告

海普瑞:截至二零二五年十二月三十一日止年度全年业绩公告及建议变更未动用所得款项净额用途

2026-03-30 港股财报 浮云
报告封面

SHENZHENHEPALINK PHARMACEUTICAL GROUP CO., LTD.9989 1.5,438.35,258.92.1,677.61,739.330.8%33.1%3.3,500.42,986.133.6%31.8%4.API784.81,065.724.8%38.6%5.CDMO1,033.01,033.834.1%32.9%6.349.5646.77.1.452.5060.9%56.7% 342,636624,918 12,678,38713,644,287 598,2211,442,166 12,080,16612,202,121 1,467,2961,467,29610,563,64410,681,377 12,030,94012,148,673 49,22653,448 12,080,16612,202,121 (IMF)(GDP)3.3%3.2%(UNCTAD)357%3.8%(3.8%)(3.3%)2.2%3.3% IMFGDP2.1%IMFGDP1.4%(GDP)5.0%(GDP)14017.1%52%3.8% 5.0% 3.35.5(GMP)(EMA)5G 5,438.33.4%1,677.63.5%30.8%2.3342.6349.546.0% (i)(ii)(CDMO)(iii) 4,285.25.8%3,500.417.2%64.4%1,174.523.6%33.6%1.8 API784.824.8%APIAPI CDMO CDMO1,0331.2CytovanceBiologics, Inc.SPL Acquisition Corp.SPLCDMO H1710 H1710H1710H1710NMPAH1710H1710II H1710H1710H1710 Oregovomab OregovomabCA125OncoQuest Inc.IIOregovomabOregovomabIII (DSMB)OregovomabOregovomab(OrientEuroPharma Co., Ltd.) AR-301 (Salvecin) AR-301IgG1(mAb)Aridis Pharmaceuticals, Inc.AridisAR-301FDAE M ATosatoxumab (AR-301)(SOC)IIITosatoxumab65(MRSA)AridisFDAEMAIIITosatoxumab RVX-208 (Apabetalone) RVX-208(BET)Resverlogix Corp.RVXRVX-208III(BETonMACE)II(HDL)FDAFDAIIIApabetaloneFDARVX-208 API SPLCDMOCDMOCDMO 5.5CSOCMO (1)API (2) 165.34,322.879.5%4,157.579.0% 241.03,760.63,519.6(i)(ii) (1)API(2) 1,739.361.71,677.633.1%2.330.8%(i)7.636.5(ii) 70.574.7145.248.5% 59.6101.3 349.5646.7 0.240.44 1,188.51,421.8 2,605.12,367.2298.11,081.0 811.72,922.0 16,631.817,343.54,551.65,141.427.4%29.6% 63.7%69.6% 1,638.12,604.21,265.0844.0 1. 002399.SZH99892130474724 2.1 (a)(b)(c) 2.2 21 (a) 3. (a)(b)APIAPIAPI(c)CDMO(d) 10%718,589,000 10%561,367,000 4. (i) 53,00322,859211,006344,743 (ii) CDMO 15FFS CDMO * ** 6. 7. *** 8. 115,57753,851 (55,973)47,460 59,604101,311 9. 1,467,296,2041,467,296,204 257,067299,692 3090 12. 14.525.0 212,758366,824 13. 1,467,296,2041,467,296,2041,467,2961,467,296 H HH3,538.430%1,061.530%1,061.520%707.720%707.7 52.8 1,034.41,013.8311.6117.51,008.352.8 H5,2805,280 5% 2,163792.2640.9 C1 1.45 HHH H i. HHH1617 ii. HHH1617 C3 (h t t p : / / w w w . h e p a l i n k . c o m /)(http://www.hkexnews.hk)H